When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

苯丙酮尿症

最后审阅: 4 Nov 2024
最后更新: 14 Feb 2023

小结

定义

病史和体格检查

关键诊断因素

  • 存在的危险因素
  • 新生儿PKU筛查阳性
完整详情

其他诊断因素

  • 智力残疾
  • 小头畸形
  • 湿疹
  • 眼睛和头发色素减少
  • 惊厥
  • 鼠臭尿液
完整详情

危险因素

  • PKU 家族史
  • 白人血统
完整详情

诊断性检查

首要检查

  • 新生儿代谢性疾病筛查
完整详情

需考虑的检查

  • 血浆氨基酸的定量分析
  • 血二氢蝶啶还原酶(DHPR)检测
  • 尿液中新喋呤(neopterin)与生物喋呤(biopterin)的比值
  • 苯丙氨酸羟化酶基因的突变分析
  • 四氢生物喋呤(BH4)敏感性试验
完整详情

治疗流程

急症处理

所有患者

撰稿人

作者

Barbara K. Burton, MD

Professor of Pediatrics

Northwestern University Feinberg School of Medicine

Director

PKU Clinic

Ann and Robert H. Lurie Children’s Hospital of Chicago

Chicago

IL

利益声明

BKB has received consulting fees and honoraria from Biomarin for speaking engagements. She has conducted contract research funded by Biomarin and Homology Medicines.

同行评议者

Berthold Koletzko, MD

Professor of Pediatrics

University of Munich

Head of Division of Metabolic Diseases and Nutritional Medicine

Dr von Hauner Children's Hospital

Ludwig-Maximilians-University of Munich

Lindwurmstr

Germany

利益声明

BK has received research support from Danone Medical Nutrition and is the recipient of a Freedom to Discover Award of the Bristol Myers Squibb Foundation.

Stephanie Sacharow, MD

Medical Geneticist

Division of Genetics and Genomics

Boston Children's Hospital

Boston

MA

利益声明

SS has participated on advisory boards and has given talks at conferences sponsored by Biomarin. She has been a principal investigator in studies with Biomarin, Synlogic, and PTC Therapeutics.

内容使用需遵循免责声明